|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01541 IMMUNEONCO-B
Nominal 
11.120 +0.120 (+1.091%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.50
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | -84.00 RMB (cts) | |
| Net Profit | -315.86 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | -367.35 | -95.50 | 0 | -- | -263.80 | -470.89 |
| 2026 | -468.13 | -121.50 | 0 | -- | -342.63 | -593.64 |
| 2027 | -189.23 | -47.00 | -- | -189.23 | -189.23 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | -263.80 | -65.00 | -- | GUOYUAN SEC | Buy | 21.89 | 03/06/2025 | |
| 2025 | -470.89 | -126.00 | -- | MORGAN STANLEY | Equal-weight | 5.25 | 13/03/2025 | |
| 2026 | -342.63 | -84.00 | -- | GUOYUAN SEC | -- | -- | 03/06/2025 | |
| 2026 | -593.64 | -159.00 | -- | MORGAN STANLEY | -- | -- | 13/03/2025 | |
| 2027 | -189.23 | -47.00 | -- | GUOYUAN SEC | -- | -- | 03/06/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 21/07/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |